41 Subtotal Resection of Sporadic Vestibular Schwannoma



10.1055/b-0039-169195

41 Subtotal Resection of Sporadic Vestibular Schwannoma

Ashkan Monfared and Robert K. Jackler

41.1 Background


The controversy over partial resection of large vestibular schwannomas (VSs) is in no way a new topic. The question dates back to two of the earlier protagonists of VS surgery, namely, Harvey Cushing and Walter Dandy. Possibly fueled by aversion to one another’s growing prominence, this issue became one of the central points of their feud.s. Literatur Dandy, advocated a total resection of these tumors,s. Literatur whereas Cushing was the main proponent of partial resection.s. Literatur While every one of Dandy’s patients suffered complete facial paralysis, many of Cushing’s patients demised from recurrence of large remnants a few years after surgery.s. Literatur With the advances in microsurgery over the next century, most surgeons came to endorse total resection in all but select elderly and fragile patients.s. Literatur ,​ s. Literatur However, as the focus of surgery has now shifted from preservation of life to preservation of function, many surgeons are more willing to entertain less-than-total resection of larger tumors in favor of preservation of facial function.



41.2 Definition of Subtotal and Near-Total Resection


Currently, there is no widely acceptable definition of degree of resection when the entire tumor has not been extirpated. One encounters terms such as “partial,” “subtotal,” “near-total,” “intracapsular,” and “radical subtotal” for various degrees of less-than-total resection. The most widely accepted terms are “near-total” and “subtotal” resection (Fig. 41‑1 ). Many surgeons resort to descriptive terms and do not provide exact dimensions or percentage of the tumor resected when using subtotal (STR) or near-total (NTR) designation.s. Literatur ,​ s. Literatur ,​ s. Literatur Few have adopted criteria established by the consensus meeting in 2003.s. Literatur In this consensus statement, NTR was defined as tumor residual measuring less than 2% of the original tumor by volume, and partial resection deemed as up to 5% of the tumor and any larger tumor remnant was designated as STR. As the authors attested, this classification is very subjectives. Literatur and there are major issues with its adoption. First, it is very difficult for most surgeons to make a precise measurement of the tumor remnant during surgery. Several studies have confirmed the poor relation between postoperative MRI findings and surgeon’s estimation of tumor remnant volume.s. Literatur ,​ s. Literatur Second, using percentage as a defining criterion is faulty as 5% of a tumor measuring 2 cm in diameter (volume of approximately 4.19 cm3) is 0.21 cm3 but 5% of a 4-cm tumor (volume of approximately 33.51 cm3) measures 1.67 cm3. The latter tumor remnant is eight times larger than the former. Others have proposed a definition based on actual size of the remnant. For example, Bloch et al recommended a remnant of 5 × 5 × 2 mm or smaller to be considered a NTR and anything larger to be categorized as STR (Fig. 41‑2 ). What this definition does not account for is the potential clinical outcome difference between remnants measuring 0.5 and 5 cm3 both of which are considered STRs.

Fig. 41.1 (a) Partial resection of a large vestibular schwannoma. (b) Subtotal resection of a large vestibular schwannoma with nodular enhancement along the course of the facial nerve. (c) Tumor residual 6–12 months after subtotal resection. Note the tumor has coalesced, or “balled up,” into a shorter and wider remnant. (d) Near-total resection of vestibular schwannoma, with a small thin pad of tumor in the region of the porus acusticus.
Fig. 41.2 Near-total resection of a left-sided vestibular schwannoma. A small residual tumor pad was left of the facial nerve at the porus acusticus in order to preserve neural integrity. (Used with permission, Jacob et al. Volumetric analysis of tumor control following subtotal and near-total resection of vestibular schwannoma. Laryngoscope 2016;126(8):1877–1882.)



41.3 Facial Nerve Outcomes as Related to Degree of Resection


The impetus behind a less-than-total resection is mostly preservation of facial nerve function. The majority of the literature demonstrates that excellent short-term and long-term facial nerve preservation rates are not optimal for larger tumors after gross-total resection (GTR). Surgeons with large series have reported rates between 33 and 73% of good facial nerve outcomes (i.e., House–Brackmann [HB] grades I–II) following more definitive surgery.s. Literatur ,​ s. Literatur ,​ s. Literatur ,​ s. Literatur ,​ s. Literatur ,​ s. Literatur ,​ s. Literatur ,​ s. Literatur Conversely, when surgeons have performed planned STR as first stage of treatment to be followed by radiation or a second-stage operation, they have achieved much better results. It is not surprising that rates of 85 to 100% good facial nerve function are achieved when the plane between the tumor and thinned-out frail facial nerve or the brainstem is not engaged.s. Literatur ,​ s. Literatur In a systematic review of studies on resection of large VSs, the extent of tumor resection was reported on 471 of the 1,688 patients eligible for the analysis. The review demonstrated a strong and significant association between degree of resection and good/excellent facial nerve outcome (HB grades I–II). The rate of good facial nerve function was 92.5% for the 80 patients receiving STR, compared to 74.6% (n = 55) for NTR and 47.3% (n = 336) for GTR.s. Literatur


The intraoperative decision as to when any further dissection would result in deterioration of the facial nerve has been largely left to the surgeon discretion. As one can imagine, this point is highly dependent on surgeon’s comfort and experience as well as what they envision appropriate based on patient’s demographics and wishes. More recently, some surgeons have advocated use of electrophysiologic properties of the nerve to help guide the extent of resection. In the study of Haque et al, the authors advocated for STR if a minimum of 0.3 mA was needed to stimulate the nerve at the brainstem or an increase of 0.1 mA from baseline was observed.s. Literatur In a similar study, continuous intraoperative evoked facial nerve electromyography (EMG) demonstrated worse outcome when the amplitude fell 50% below the initial value.s. Literatur Schmitt et al reported reliable prognostic value using pulsed constant-current stimulation at supramaximal levels at the root exit zone compared to the peripheral segment exiting the stylomastoid foramen. They reported that for patients who had proximal-to-distal drop off of over 69%, the rate of long-term poor facial function was 44% compared to 6% for patient with values less than 69%. This method was suggested by the authors as a potential viable method to guide degree of less-than-total resection.s. Literatur Further discussion regarding facial nerve function prognostication using intraoperative stimulation testing is reviewed in greater detail in Chapter 27.



41.4 Tumor Control Rate as a Function of Degree of Resection


The main concern with performing less-than-total resection is that the remnant tumor would require treatment within a few years. As is the case with defining the degree of resection, currently no universal definition exists for “growth of remnant” or “failure of treatment” in our literature. Studies have used radiologic definitions anywhere between 1 and 5 mm of growth in the diameter of the tumor as clinical definition of failure.s. Literatur ,​ s. Literatur ,​ s. Literatur This is one reason why the rates of recurrence after less-than-total resection vary so widely in the literature.s. Literatur ,​ s. Literatur ,​ s. Literatur ,​ s. Literatur ,​ s. Literatur A second source of variance in reporting is the duration of follow-up. It is clear in the literature that the reported rate of recurrence increases as the duration of follow-up is extended. Thus, the risk of recurrence is best summarized using time to event analysis, such as the Kaplan–Meier method. On average, approximately one-third of patients who have undergone STR would develop tumor regrowth, whereas the regrowth rate among GTR and NTR patients is usually in single digits. For example, Bloch et al found that the rate of regrowth for their NTR population was 3% compared to 32% for STR.s. Literatur Similarly Seol et al reported statistically significant regrowth rates of 3.8, 9.4, and 27.6% in their GTR, NTR, and STR population, respectively.s. Literatur Table 41‑1 summarizes select large publications reporting rates of regrowth following less-than-complete VS resection.
































































































































Table 41.1 Select large published series reporting rates of facial nerve function and regrowth following less-than-complete vestibular schwannoma resection

Study


Center


Design


Number


Duration of follow-up


Definition STR/NTR


Facial function


Recurrence rate


Predictors of recurrence


Bloch et al (2004)


University of California, San Francisco, CA


Retrospective


50 NTR, 29 STR


Mean: 4.3 y (range: 1–13 y)


NTR: residual ≤ 25 mm2 and 2 mm thick


STR: residual larger than NTR


Good FN function (HB I–II) at 1 y postoperatively in 81% of patients


Logistic regression analysis demonstrated no statistically significant difference in good facial nerve function between the NTR and STR groups when controlling for age, tumor size, and operative approach


NTR: 3% recurrence


STR: 32% recurrence


After adjustment for follow-up time and tumor size, the odds ratio for recurrence was 12 times larger for STR than for NTR


(p = 0.033)


Godefroy et al (2009)


Leiden University Medical Centre, Leiden, The Netherlands


Retrospective


29 NTR, 8 STR


Mean: 48 mo


NTR: < 5% of initial tumor volume remaining, but not GTR


STR: > 5% of initial tumor volume remaining


NTR: 76% with good FN function (HB I–II)


STR: 100% with good FN function (HB I–II)


NTR + STR: 6%; did not differentiate between NTR and STR



Sughrue et al (2011)


University of California, San Francisco, CA


Prospective


89 NTR, 112 STR


Median 37 mo


NTR: only a thin layer of tumor attached to one or more nerves; the amount of residual tumor appears similar to GTR on imaging


STR: imaging studies or intraoperative impression revealing gross evidence of residual disease


NR


NTR: 84% tumor control at 5 y, 81% tumor control at 10 y


STR: 82% tumor control at 5 y, 82% tumor control at 10 y



Fukuda et al (2011)


University of Niigata, Japan


Retrospective


25 STR, 8 PR


Mean: 104.1 mo (range: 60–241 mo)


STR: 1–10% of initial tumor volume remaining


PR: >10% of initial tumor volume remaining


STR: 60% with good FN function (HB I–II)


PR: 88% with good FN function (HB I–II)


NTR: 52% recurrence


STR: 63% recurrence


Times to recurrence ranged from 6 to 76 mo (median 31.9 mo)


Univariate and multivariate analyses of various factors revealed that thickness of the residual tumor, based on MR imaging after surgery, and the MIB-1 index were positively related to residual tumor regrowth.
The receiver operating characteristic curves, plotted for both the thickness of the residual tumor and the MIB-1 index, identified the optimal cutoff points for these values as 7.4 mm (sensitivity 83.3%, specificity 86.7%) and 1.6 (sensitivity 83.3%, specificity 66.7%), respectively


Carlson et al (2012)


Mayo Clinic, Rochester MN


Retrospective


32 NTR, 27 STR


Mean: 3.5 y (range: 0.3–9.3 y)


NTR: residual less than 5 × 5 × 2 mm


STR: residual larger than NTR


NR


NTR: 3% overall recurrence; 93% estimated recurrence-free survival rate at 5 y following surgery


STR: 22% overall recurrence; 71% estimated recurrence-free survival rate at 5 y following surgery


STR, nodular enhancement, nodule volume >0.4 cm3, and maximum nodule dimensions >15 mm were statistically significantly associated with recurrence. Patients treated with STR were more than nine times more likely to develop recurrence compared with those treated with GTR (hazard ratio, 9.4; p < 0.001), and subjects with nodular enhancement on baseline postoperative MRI were at a 16-fold increased risk for later recurrence compared to those with linear patterns (hazard ratio, 16.5; p = 0.008)


Schwartz et al (2013)


The House Clinic, Los Angeles CA


Retrospective


44 NTR, 31 STR


Mean: 3.7 y (range: 1.0–9.8 y)


NTR: only thin layer of tumor capsule (<1 cm) remaining on the facial nerve


STR: ≥1 cm residual remaining


NTR: 78 and 97% with good FN function (HB I–II) at the postoperative and 1-y follow-up time points, respectively


STR: 71 and 96% with good FN function (HB I–II) at the postoperative and 1-y follow-up time points, respectively


NTR: 21% recurrence


STR: 22% recurrence


The mean times to recurrence for those tumors that grew, based on first to last MRI, were 4.0 and 4.3 y in the NTR and STR groups, respectively


The NTR and STR groups had a significantly higher rate of regrowth than GTR resection (21 and 22% vs. 3%) at average follow-up times of 3.7, 3.7, and 5.1 y, respectively


Need for further treatment occurred at a higher rate, although infrequently, in NTR and STR (2 and 10% vs. 0%)


Chen et al (2014)


Gruppo Otologico, Piacenza-Rome, Italy


Retrospective


73 NTR, 38 STR


Mean: 45.4 mo (range: 12–156 mo)


NTR: <2% of initial tumor volume remaining, but not GTR


STR: 2–5% of initial tumor volume remaining


PR: >5% of initial tumor volume remaining


NTR: 49% with good FN function (HB I–II) at 1 y postoperatively


STR: 47% with good FN function (HB I–II) function at 1 y postoperatively


There was no significant difference in good, intermediate, and unsatisfactory facial nerve function between groups


NTR: 0% recurrence


STR: 18% recurrence


The 5-y tumor regrowth–free survival was 92%, with a mean tumor regrowth–free period of 140 mo (95% CI: 127–151 mo)



Jacob et al (2015)


Mayo Clinic, Rochester MN


Retrospective


50 NTR, 53 STR


Mean: 56.1 mo (range: 12–150 mo)


NTR: residual < 5 × 5 × 2 mm


STR: residual larger than NTR


NTR: 82% with good FN (HB I–II) function


STR: 81% with good FN (HB I–II) function


Postoperative FN function was not statistically significantly different between groups even after adjusting for tumor size in a multivariable setting


NTR: Estimated recurrence-free survival rates (95% CI; number still at risk) at 24, 48, 72, 96, and 120 mo were 100% (100–100; 45), 100% (100–100; 25), 100% (100–100; 15), 100% (100–100; 10), and 90% (73–100; 6), respectively


STR: Estimated recurrence-free survival rates (95% CI; number still at risk) at 24, 48, 72, and 96 mo were 96% (90–100; 42), 71% (57–89; 17), 67% (51–86; 10), and 67% (51–86; 6), respectively


The median time to recurrence following NTR was 124 mo (range: 98–136) compared to only 32 mo (range: 21–55) after STR (p < 0.001)


STR was 13 times more likely to recur compared to NTR (HR: 13.31; 95% CI: 1.71–103.91; p = 0.014)


Monfared et al (2015)


Multicenter


Prospective


22 NTR, 39 STR


Mean: 38 mo (range: 12–96 mo)


NTR: residual < 5 × 5 × 2 mm


STR: when the tumor was resected 80–90% by volume and 60–70% by surface area


FN function at the first postoperative visit and at the ≥1 year postoperative visit was not associated with degree of resection as reported by the surgeon or as determined by postoperative MRI


NTR: 9.1%


STR: 28.2%


The average time from surgery until regrowth was 35 mo (range: 4–74 mo)


Tumor regrowth was related to longer follow-up (p = 0.0002), noncystic tumor (29 vs. 5%; p = 0.02), larger residual tumor percentage by volume (p = 0.003), and STR as defined by the surgeon (p = 0.02)


Nakatomi et al (2017)


Mayo Clinic, Rochester MN


Retrospective


18 STR


Median 7.1 y (range: 1.0–26.3 y)


STR: anything less than GTR


NR


STR: 83% recurrence at a median of 2.7 y following resection (IQR: 1.9–8.9, range: 1.2–18.7)


Estimated recurrence-free survival rates at 5, 10, and 15 y following STR were 47% (95% CI: 28–78, 7 patients still at risk), 17% (5–55, 2), and 8% (1–52, 1), respectively


STR with nearly an 11-fold greater risk of recurrence than GTR (HR: 10.55, p < 0.001)


Abbreviations: HB, House–Brackmann; GTR, gross-total resection; NTR, near-total resection; STR, subtotal resection


Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 13, 2020 | Posted by in NEUROSURGERY | Comments Off on 41 Subtotal Resection of Sporadic Vestibular Schwannoma

Full access? Get Clinical Tree

Get Clinical Tree app for offline access